Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on October 12, 2006

Arteriosclerosis, Thrombosis, and Vascular Biology. 2006
Published online before print October 12, 2006, doi: 10.1161/01.ATV.0000249639.36915.04
A more recent version of this article appeared on December 1, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
26/12/2775    most recent
01.ATV.0000249639.36915.04v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chironi, G.
Right arrow Articles by Tedgui, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chironi, G.
Right arrow Articles by Tedgui, A.

Submitted on June 26, 2006
Accepted on September 25, 2006

Circulating Leukocyte-Derived Microparticles Predict Subclinical Atherosclerosis Burden in Asymptomatic Subjects

Gilles Chironi ; Alain Simon *; Bénédicte Hugel ; Muriel Del Pino ; Jérôme Gariepy ; Jean-Marie Freyssinet ; and Alain Tedgui

From AP-HP, Hôpital Broussais (G.C., A.S., M.D.P., J.G.), Centre de Médecine Préventive Cardiovasculaire, Paris, France; Université René Descartes (G.C., A.S., M.D.P., J.G.), Paris, France; Unité INSERM U770 (B.H., J.M.F.), Hôpital Bicêtre, Le Kremlin Bicêtre; Institut d’Hématologie et d’Immunologie, Faculté de Médecine, Université Louis Pasteur, Strasbourg, France; Unité INSERM U689 & Institut Fédératif de Recherche Circulation (A.T.), Paris, France.

* To whom correspondence should be addressed. E-mail: alain.simon{at}brs.aphp.fr.

Objective--To clarify circulating microparticles (MP) relationships with preclinical atherosclerosis.

Methods and Results--In 216 subjects without cardiovascular disease, we assessed: (1) annexin V-positive, platelet-derived, endothelium-derived and leukocyte-derived circulating MP by capture on annexin V, anti-GPIb, anti-CD105, and anti-CD11a antibody-coated wells, respectively; (2) Framingham risk, metabolic syndrome, and low-grade inflammation by risk factors measurement including hsCRP; and (3) subclinical atherosclerosis by ultrasound examination of carotid, abdominal aorta, and femoral arteries. Number of sites with plaque ranged from 0 to 3 and plaque burden was classified into 0 to 1 or 2 to 3 sites disease. Leukocyte-derived MP level was higher in the presence than in the absence of moderate to high Framingham risk (P<0.05), metabolic syndrome (P<0.01), high C-reactive protein (CRP) (P<0.05), or 2- to 3-site disease (P<0.01), and correlated positively with number of metabolic syndrome components (P<0.001), tertiles of fibrinogen (P<0.001), and number of diseased sites (P<0.01). In multivariate analysis, 2- to 3-site disease was independently associated with leukocyte-derived MP level (P<0.05), Framingham risk (P<0.001), and metabolic syndrome (P<0.01). None of the other MP types correlated with risk markers or atherosclerosis.

Conclusions--Leukocyte-derived MP, identified by affinity for CD11a, are increased in subjects with ultrasound evidence of subclinical atherosclerosis, unveiling new directions for atherosclerosis research.


Key words: atherosclerosis • leukocytes • microparticles • risk factors • ultrasonic diagnosis




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
J. I. Zwicker, H. A. Liebman, D. Neuberg, R. Lacroix, K. A. Bauer, B. C. Furie, and B. Furie
Tumor-Derived Tissue Factor-Bearing Microparticles Are Associated With Venous Thromboembolic Events in Malignancy
Clin. Cancer Res., November 15, 2009; 15(22): 6830 - 6840.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
L. Ayers, B. Ferry, S. Craig, D. Nicoll, J. R. Stradling, and M. Kohler
Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea
Eur. Respir. J., March 1, 2009; 33(3): 574 - 580.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
O. Morel, F. Toti, N. Morel, and J.-M. Freyssinet
Microparticles in endothelial cell and vascular homeostasis: are they really noxious?
Haematologica, March 1, 2009; 94(3): 313 - 317.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. Pasterkamp and D. de Kleijn
Microparticles, Debris That Hurts
J. Am. Coll. Cardiol., October 14, 2008; 52(16): 1312 - 1313.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Agouni, A. H. Lagrue-Lak-Hal, P. H. Ducluzeau, H. A. Mostefai, C. Draunet-Busson, G. Leftheriotis, C. Heymes, M. C. Martinez, and R. Andriantsitohaina
Endothelial Dysfunction Caused by Circulating Microparticles from Patients with Metabolic Syndrome
Am. J. Pathol., October 1, 2008; 173(4): 1210 - 1219.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Jayachandran, R. D. Litwiller, W. G. Owen, J. A. Heit, T. Behrenbeck, S. L. Mulvagh, P. A. Araoz, M. J. Budoff, S. M. Harman, and V. M. Miller
Characterization of blood borne microparticles as markers of premature coronary calcification in newly menopausal women
Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H931 - H938.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. J. Stampfuss, P. Censarek, D. Bein, K. Schror, M. Grandoch, C. Naber, and A.-A. Weber
Membrane environment rather than tissue factor expression determines thrombin formation triggered by monocytic cells undergoing apoptosis
J. Leukoc. Biol., June 1, 2008; 83(6): 1379 - 1381.
[Abstract] [Full Text] [PDF]